Form EFFECT FibroBiologics, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 14, 2025 4:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FibroBiologics completes third drug batch for diabetic foot ulcer trial
- Both Leading Independent Proxy Advisors Recommend Aterian Stockholders Vote for the Asset Sale
- New Esri Press Book Shows That GIS Can Transform the Entire Campus, Starting at the Classroom
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share